The company received USFDA approval for nonsteroidal anti-inflammatory drug, which will be produced at Ahmedabad facility.

The company said that the medicine is used to treat pain or inflammation caused by many conditions such as arthritis, ...

Zydus Lifesciences announced that the USFDA conducted a Remote Regulatory Assessment (RRA) at Zydus' formulations manufacturing facility at Matoda in Gujarat for the Prior Approval Supplement (PAS) of ...

Ahmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) ...

Stocks like Tech Mahindra, Angel One, L&T Technology Services, Le Travenues Technology, Maruti Suzuki India, State Bank of ...

Zydus Lifesciences gets USFDA nod for Celecoxib capsules. The approval includes various strengths of the drug. It will ...

Ahmedabad: Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and Drug Administration ...

Biocon and Zydus Lifesciences are in the spotlight with fresh regulatory approvals fueling bullish analyst sentiment and renewed retail interest. Biocon shares rose 2% on Wednesday after its ...

The Subject Expert Committee (SEC) under the Reproductive division of the Central Drugs Standard Control Organisation (CDSCO) ...

Dubai: Share prices of Indian pharmaceutical companies – and especially those with high export volumes – are coming under investor spotlight after the latest tariff threat from US President Trump. Of ...

After identifying the top-100 large cap stocks, the stocks ranked 101st to 250th by market cap qualify as mid-cap stocks.

On Wednesday, 2338 stocks advanced, 1718 declined and 163 remained unchanged on Bombay Stock Exchange with advance decline ratio of 1.36 indicating a positive closing in the broader market, as foreign ...